Statements (50)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:birthYear |
2010
|
gptkbp:hasAmenities |
gptkb:ISO_9001
|
gptkbp:hasClient |
Pharmaceutical Companies
Biotechnology Firms Medical Device Manufacturers |
gptkbp:hasEmployees |
50-100
|
gptkbp:hasExhibition |
Clinical Trials
Risk Management Quality Assurance FDA_Regulations |
gptkbp:hasGoals |
Consulting
|
gptkbp:hasLocation |
gptkb:United_States
|
gptkbp:hasPartnershipsWith |
Industry Associations
|
gptkbp:hasResidence |
5 million USD
|
gptkbp:hasService |
Crisis Management
Due Diligence Regulatory Compliance Stakeholder Engagement Technical Writing Compliance Audits Policy Advocacy Training and Workshops Regulatory Submissions Post-Market Surveillance Regulatory Affairs Support Regulatory Compliance Audits Regulatory Affairs Consulting Regulatory Risk Assessment Regulatory Intelligence Regulatory Training Programs Regulatory Strategy Development Documentation Preparation Labeling Compliance Labeling and Advertising Compliance Market Access Strategy Market Authorization Support Regulatory Affairs Management Regulatory Affairs Outsourcing Regulatory Affairs Training Regulatory Policy Analysis Regulatory Strategy Consulting Pharmacovigilance_Services Clinical_Study_Support Health_Economics_Consulting Product_Development_Consulting Regulatory_Documentation_Services |
gptkbp:hasWebsite |
www.regulatoryadvisors.com
|
https://www.w3.org/2000/01/rdf-schema#label |
Regulatory Advisors Corp.
|
gptkbp:keyPeople |
gptkb:John_Doe
|